Agile Therapeutics, Inc. Comprehensive Income
Agile Therapeutics, Inc. reported Comprehensive Income of -$14.46 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2024-03-28
- Agile Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$3.93M.
- Agile Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$5.93M.
- Agile Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-06-30 was -$5.17M.
- Agile Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-03-31 was -$10.38M.
- Agile Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$14.46M.
- Agile Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$25.41M.
- Agile Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$71.07M.
- Agile Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$51.85M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | -$14.46M 10-K · filed 2024-03-28 | |||||||
| 2022-12-31 | -$3.93M derived: 10-K 12 month − 10-K 9 month · filed 2024-03-28 | -$9.86M derived: sum of 2 quarters · filed 2024-03-28 | -$15.03M derived: sum of 3 quarters · filed 2024-03-28 | -$25.41M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$5.93M 10-K · filed 2023-03-23 | -$19.67M 10-Q · filed 2022-11-07 | -$11.10M derived: sum of 2 quarters · filed 2023-03-23 | -$21.48M 10-K · filed 2023-03-23 | -$43.65M 10-Q · filed 2022-11-07 | -$41.01M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-06-30 | -$5.17M 10-K · filed 2023-03-23 | -$12.22M 10-Q · filed 2022-08-11 | -$15.55M 10-K · filed 2023-03-23 | -$23.99M 10-Q · filed 2022-08-11 | -$35.08M derived: sum of 3 quarters · filed 2024-03-28 | -$51.85M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-03-31 | -$10.38M 10-K · filed 2023-03-23 | -$11.77M 10-Q · filed 2022-05-12 | -$29.91M derived: sum of 2 quarters · filed 2024-03-28 | -$46.69M derived: sum of 3 quarters · filed 2024-03-28 | -$64.32M derived: sum of 4 quarters · filed 2024-03-28 | |||
| 2021-12-31 | -$19.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$36.30M derived: sum of 2 quarters · filed 2024-03-28 | -$53.94M derived: sum of 3 quarters · filed 2024-03-28 | -$71.07M 10-K · filed 2024-03-28 | -$74.90M 10-K · filed 2022-03-30 | |||
| 2021-09-30 | -$16.77M 10-Q · filed 2022-11-07 | -$34.41M derived: sum of 2 quarters · filed 2022-11-07 | -$51.54M 10-Q · filed 2022-11-07 | -$69.17M derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2021-06-30 | -$17.64M 10-Q · filed 2022-08-11 | -$34.77M 10-Q · filed 2022-08-11 | -$52.40M derived: sum of 3 quarters · filed 2023-03-23 | -$67.92M derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2021-03-31 | -$17.13M 10-Q · filed 2022-05-12 | -$34.76M derived: sum of 2 quarters · filed 2023-03-23 | -$50.28M derived: sum of 3 quarters · filed 2023-03-23 | -$61.10M derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2020-12-31 | -$17.63M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-23 | -$33.15M derived: sum of 2 quarters · filed 2023-03-23 | -$43.97M derived: sum of 3 quarters · filed 2023-03-23 | -$51.85M 10-K · filed 2023-03-23 | ||||
| 2020-09-30 | -$15.52M 10-Q/A · filed 2021-12-30 | -$26.34M derived: sum of 2 quarters · filed 2021-12-30 | -$34.22M 10-Q/A · filed 2021-12-30 | -$40.24M derived: sum of 4 quarters · filed 2022-03-30 | ||||
| 2020-06-30 | -$10.82M 10-Q · filed 2021-07-26 | -$18.70M 10-Q · filed 2021-07-26 | -$24.72M derived: sum of 3 quarters · filed 2022-03-30 | -$29.15M derived: sum of 4 quarters · filed 2022-03-30 | ||||
| 2020-03-31 | -$7.88M 10-Q · filed 2021-05-04 | -$13.90M derived: sum of 2 quarters · filed 2022-03-30 | -$18.34M derived: sum of 3 quarters · filed 2022-03-30 | -$21.82M derived: sum of 4 quarters · filed 2022-03-30 | ||||
| 2019-12-31 | -$6.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$10.45M derived: sum of 2 quarters · filed 2022-03-30 | -$13.94M derived: sum of 3 quarters · filed 2022-03-30 | -$18.61M 10-K · filed 2022-03-30 | ||||
| 2019-09-30 | -$4.43M 10-Q · filed 2020-11-12 | -$7.92M derived: sum of 2 quarters · filed 2020-11-12 | -$12.59M 10-Q · filed 2020-11-12 | |||||
| 2019-06-30 | -$3.48M 10-Q · filed 2020-08-11 | -$8.15M 10-Q · filed 2020-08-11 | ||||||
| 2018-12-31 | -$19.78M 10-K · filed 2021-03-01 |